A major discovery in cancer research is emerging with the use of VHH fragments to re-engage dysfunctional p53. This essential malignant protector protein is frequently inactivated in several types of malignancies, https://letusbookmark.com/story23961031/nanobodies-restore-p53-the-promising-hope-for-tumor-management